(Q43982583)

English

Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats

scientific article published on June 21, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats (English)

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

T. M. Engber

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717109

7 November 2022

Z. Susel

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717109

7 November 2022

S. Kuo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717109

7 November 2022

C. R. Gerfen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717109

7 November 2022

T. N. Chase

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717109

7 November 2022

language of work or name

0 references

publication date

1 June 1991

1 reference

Europe PubMed Central

28 November 2017

21 June 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1717109

7 November 2022

full work available at URL

https://api.elsevier.com/content/article/PII:000689939190667K?httpAccept=text/xml

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

https://api.elsevier.com/content/article/PII:000689939190667K?httpAccept=text/plain

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

1 reference

Europe PubMed Central

28 November 2017

552

1 reference

Europe PubMed Central

28 November 2017

1

1 reference

Europe PubMed Central

28 November 2017

113-118

1 reference

Europe PubMed Central

28 November 2017

The functional anatomy of basal ganglia disorders

1

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: An evolutionarily conserved feature of basal ganglia organization

2

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons

3

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

L-Dopa methyl ester--a candidate for chronic systemic delivery of L-Dopa in Parkinson's disease

5

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra

6

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists

7

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Chronic levodopa treatment alters basal and dopamine agonist-stimulated cerebral glucose utilization.

8

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

9

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study

10

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Characterization of methamphetamine effects on the striatal-nigral dynorphin system

11

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.

14

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Continuous and intermittent levodopa differentially affect basal ganglia function

15

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin

16

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations

17

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Protein measurement with the Folin phenol reagent

20

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Success and problems of long-term levodopa therapy in Parkinson's disease

21

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism

22

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies

23

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.

24

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Isolated removal of hypothalamic or other brain nuclei of the rat

25

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle

26

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat.

27

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Control of on/off phenomenon by continuous intravenous infusion of levodopa

29

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Changes in the activity of GAD in the basal ganglia of the rat after striatal dopaminergic denervation.

31

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

In vivo inhibition of striatal acetylcholine turnover by L-DOPA, apomorphine and (+)-amphetamine

32

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Increased striatal glutamate decarboxylase after lesions of the nigrostriatal pathway

33

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions.

34

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration

35

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Metabolic effects of unilateral lesion of the substantia nigra

36

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis

37

1 reference

10.1016/0006-8993(91)90667-K

https://api.crossref.org/works/10.1016/0006-8993(91)90667-K

7 November 2022

Identifiers

10.1016/0006-8993(91)90667-K

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43982583&oldid=1766314198"